Premium
Apollo Education Grp., Inc. (APOL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
es PLC - London-based medical cannabis pharmaceutical firm - On Wednesday, said intends to withdraw its shares from tr ...
Apollon Formularies PLC on Tuesday said that a peer-reviewed publication publicised successful cancer cell-killing re ...
es PLC - London-based medical cannabis pharmaceutical firm - Says concludes due diligence with Sproutly Canada, a supp ...
The following is a round-up of earnings by London-listed companies, issued last week and not separately reported by A ...
es PLC - London-based medical cannabis pharmaceutical firm - Signs exclusive license agreement with PureCann Pty Ltd, ...
es PLC - London-based medical cannabis pharmaceutical firm - Reports revenue in 2022 rose 45% to GBP286,144 from GBP19 ...
Apollon Formularies PLC on Tuesday said it has agreed a 28-day extension to complete final due diligence in order to ...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
